Pacira Pharma (PCRX) Reports Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Pacira Pharma (PCRX) Reports Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia
PACIRA (NASDAQ: PCRX) Delayed: 24.48 -0.43 (1.73%)
Previous Close $24.91    52 Week High $80.25 
Open $25.11    52 Week Low $30.25 
Day High $25.20    P/E N/A 
Day Low $24.45    EPS $-2.08 
Volume 393,793